AbbVie Inc.

AbbVie is a global, diversified research-based biopharmaceutical company that develops and markets advanced therapies. The company was incorporated in Delaware on April 10, 2012, and became an independent, publicly-traded company on January 1, 2013, following a distribution from Abbott Laboratories. AbbVie operates as a single global business segment, focusing on the research and development, manufacturing, commercialization, and sale of innovative medicines and therapies. This structure allows the Chief Executive Officer to allocate resources and assess performance globally. A global research and development and supply chain organization handles product discovery, development, manufacturing, and supply, while commercial efforts for marketing, sales, and distribution are organized by geographic region or therapeutic area. These activities are supported by a global corporate administrative staff. AbbVie's product portfolio holds leadership positions across immunology, neuroscience, oncology, and aesthetics. Its products include a broad line of therapies for complex and serious diseases, with an extensive immunology portfolio covering rheumatology, dermatology, and gastroenterology.